CervoMed (NASDAQ:CRVO) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.49) by 72.13 percent. This is a 52.73 percent decrease over losses of $(0.55) per share from the same period last year. The company reported quarterly sales of $322.569 thousand which missed the analyst consensus estimate of $1.300 million by 75.19 percent. This is a 83.37 percent decrease over sales of $1.940 million the same period last year.